These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4136163)

  • 1. Plasma TSH and serum T-4 levels in long-term follow-up of patients treated with 131-I for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Seth J
    Br Med J; 1974 Jul; 3(5924):152-3. PubMed ID: 4136163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function in patients treated with radioactive iodine for thyrotoxicosis.
    Tunbridge WM; Harsoulis P; Goolden AW
    Br Med J; 1974 Jul; 3(5923):89-92. PubMed ID: 4855207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function in the long-term follow-up of patients treated with iodine-131 for thyrotoxicosis.
    Toft AD; Irvine WJ; Seth J; Hunter WM; Cameron EH
    Lancet; 1975 Sep; 2(7935):576-8. PubMed ID: 51406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The assessment of 125I treatment of thyrotoxicosis.
    Bremner WF; Spencer CA; Ratcliffe WA; Greig WR; Ratcliffe JG
    Clin Endocrinol (Oxf); 1976 May; 5(3):225-34. PubMed ID: 954217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How often should patients be reviewed after treatment with iodine-131 for thyrotoxicosis?
    Toft AD; Irvine WJ; Seth J; Cameron EH
    Br Med J; 1978 Oct; 2(6145):1115-7. PubMed ID: 709256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-thyrotrophin and serum-thyroxine in patients becoming hypothyroid in the early months after iodine-131.
    Toft AD; Seth J; Hunter WM; Irvine WJ
    Lancet; 1974 Apr; 1(7860):704-5. PubMed ID: 4132423
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical value of a sensitive immunoradiometric assay for TSH.
    Allen KR; Scott RD; Hewitt JV; Watson D
    Ann Clin Biochem; 1985 Sep; 22 ( Pt 5)():506-8. PubMed ID: 4062219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous plasma TSH levels in patients developing hypothyroidism in the early months after 131I therapy for thyrotoxicosis.
    Toft AD; Irvine WJ; Hunter WM; Ratcliffe JG; Seth J
    J Clin Endocrinol Metab; 1974 Sep; 39(3):607-9. PubMed ID: 4412033
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum T3, T4, TSH patterns in euthyroid subjects treated with 131I for thyrotoxicosis.
    Biassoni P; Bagnasco M; Caputo M; Santaniello B; Ferrini O
    J Nucl Med Allied Sci; 1980; 24(1-2):93-8. PubMed ID: 7205396
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of thyrotoxicosis with 125-iodine: results in 93 patients 3 to 5 years after treatment, and comparison with 131-iodine therapy (author's transl)].
    Glanzmann Ch; Horst W
    Strahlentherapie; 1979 Jan; 155(1):1-5. PubMed ID: 760268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
    Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
    Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial target organ resistance to thyroid hormone.
    Bode HH; Danon M; Weintraub BD; Maloof F; Crawford JD
    J Clin Invest; 1973 Apr; 52(4):776-82. PubMed ID: 4632689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of TSH values measured in a sensitive assay in the follow-up of hyperthyroid patients treated with radioiodine.
    Davies PH; Franklyn JA; Daykin J; Sheppard MC
    J Clin Endocrinol Metab; 1992 May; 74(5):1189-94. PubMed ID: 1569166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting hypothyroidism in long-term follow-up after 131I therapy.
    Gimlette TM; Critchley M; Squire CR
    Nuklearmedizin; 1988 Aug; 27(4):135-9. PubMed ID: 3186463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
    Ridgway EC; Weintraub BD; Cevallos JL; Rack MC; Maloof F
    J Clin Invest; 1973 Nov; 52(11):2783-92. PubMed ID: 4201265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of thyroid function in patient's remaining in remission after antithyroid drug therapy for thyrotoxicosis.
    Irvine WJ; Gray RS; Toft AD; Seth J; Lidgard GP; Cameron EH
    Lancet; 1977 Jul; 2(8030):179-81. PubMed ID: 69792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.